Cimzia for treatment of adults with active ankylosing spondylitis, approved by FDA
The Food and Drug Administration ( FDA ) has approved Cimzia ( Certolizumab pegol ) for the treatment of adults with active ankylosing spondylitis ( AS ).
The FDA also issued a Complete Response Let ...
read article